FDA Approves TicoVac (tick-borne encephalitis vaccine) to Prevent Tick-Borne Encephalitis (TBE)

NEW YORK--(BUSINESS WIRE) August 13, 2021 -- Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TicoVac (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news